Department of Bioinformatics, School of Medical Technology and Engineering, Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 350122, China.
Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China.
Chin Med J (Engl). 2024 Apr 5;137(7):859-870. doi: 10.1097/CM9.0000000000002774. Epub 2023 Aug 11.
Adamantinomatous craniopharyngioma (ACP) is the commonest pediatric sellar tumor. No effective drug is available and interpatient heterogeneity is prominent. This study aimed to identify distinct molecular subgroups of ACP based on the multi-omics profiles, imaging findings, and histological features, in order to predict the response to anti-inflammatory treatment and immunotherapies.
Totally 142 Chinese cases diagnosed with craniopharyngiomas were profiled, including 119 ACPs and 23 papillary craniopharyngiomas. Whole-exome sequencing (151 tumors, including recurrent ones), RNA sequencing (84 tumors), and DNA methylome profiling (95 tumors) were performed. Consensus clustering and non-negative matrix factorization were used for subgrouping, and Cox regression were utilized for prognostic evaluation, respectively.
Three distinct molecular subgroups were identified: WNT, ImA, and ImB. The WNT subgroup showed higher Wnt/β-catenin pathway activity, with a greater number of epithelial cells and more predominantly solid tumors. The ImA and ImB subgroups had activated inflammatory and interferon response pathways, with enhanced immune cell infiltration and more predominantly cystic tumors. Mitogen-activated protein kinases (MEK/MAPK) signaling was activated only in ImA samples, while IL-6 and epithelial-mesenchymal transition biomarkers were highly expressed in the ImB group, mostly consisting of children. The degree of astrogliosis was significantly elevated in the ImA group, with severe finger-like protrusions at the invasive front of the tumor. The molecular subgrouping was an independent prognostic factor, with the WNT group having longer event-free survival than ImB (Cox, P = 0.04). ImA/ImB cases were more likely to respond to immune checkpoint blockade (ICB) therapy than the WNT group ( P <0.01). In the preliminary screening of subtyping markers, CD38 was significantly downregulated in WNT compared with ImA and ImB ( P = 0.01).
ACP comprises three molecular subtypes with distinct imaging and histological features. The prognosis of the WNT type is better than that of the ImB group, which is more likely to benefit from the ICB treatment.
造釉细胞瘤型颅咽管瘤(ACP)是最常见的儿童鞍区肿瘤。目前尚无有效的治疗药物,且患者间存在明显异质性。本研究旨在通过多组学分析、影像学表现和组织学特征,鉴定出 ACP 的不同分子亚型,以预测其对抗炎治疗和免疫治疗的反应。
共纳入 142 例中国颅咽管瘤患者,包括 119 例 ACP 和 23 例乳头型颅咽管瘤。对 151 例肿瘤(包括复发性肿瘤)进行全外显子组测序,对 84 例肿瘤进行 RNA 测序,对 95 例肿瘤进行 DNA 甲基化组谱分析。采用共识聚类和非负矩阵分解进行亚群分组,Cox 回归用于预后评估。
鉴定出 3 个不同的分子亚型:WNT、ImA 和 ImB。WNT 亚组中 Wnt/β-catenin 信号通路活性更高,上皮细胞数量更多,实性肿瘤更为多见。ImA 和 ImB 亚组中炎症和干扰素反应途径被激活,免疫细胞浸润增强,囊性肿瘤更为多见。MAPK 信号通路(MEK/MAPK)仅在 ImA 样本中被激活,而 IL-6 和上皮间质转化标志物在 ImB 组中高度表达,主要见于儿童。ImA 组的星形胶质增生程度显著升高,肿瘤侵袭前沿的指状突起明显。分子亚群是独立的预后因素,WNT 组无事件生存时间长于 ImB 组(Cox,P = 0.04)。ImA/ImB 病例比 WNT 组更有可能对免疫检查点阻断(ICB)治疗有反应(P <0.01)。在亚群标志物的初步筛选中,与 ImA 和 ImB 相比,WNT 中 CD38 的表达显著下调(P = 0.01)。
ACP 包含 3 种具有不同影像学和组织学特征的分子亚型。WNT 型的预后优于 ImB 型,后者更有可能从 ICB 治疗中获益。